Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

  • Berriman J
  • Serpell L
  • Oberg K
 et al. 
  • 91


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Abnormal filaments consisting of hyperphosphorylated microtubule-associated protein tau form in the brains of patients with Alzheimer's disease, Down's syndrome, and various dementing tauopathies. In Alzheimer's disease and Down's syndrome, the filaments have two characteristic morphologies referred to as paired helical and straight filaments, whereas in tauopathies, there is a wider range of morphologies. There has been controversy in the literature concerning the internal molecular fine structure of these filaments, with arguments for and against the cross-beta structure demonstrated in many other amyloid fibers. The difficulty is to produce from brain pure preparations of filaments for analysis. One approach to avoid the need for a pure preparation is to use selected area electron diffraction from small groups of filaments of defined morphology. Alternatively, it is possible to assemble filaments in vitro from expressed tau protein to produce a homogeneous specimen suitable for analysis by electron diffraction, x-ray diffraction, and Fourier transform infrared spectroscopy. Using both these approaches, we show here that native filaments from brain and filaments assembled in vitro from expressed tau protein have a clear cross-beta structure.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • John Berriman

  • Louise C Serpell

  • Keith a Oberg

  • Anthony L Fink

  • Michel Goedert

  • R Anthony Crowther

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free